TTE.US

59.53

+0.68%↑

EQNR.US

25.23

-0.83%↓

KMI

28.24

+0.61%↑

SLB

32.87

-0.51%↓

E

33.89

-0.12%↓

TTE.US

59.53

+0.68%↑

EQNR.US

25.23

-0.83%↓

KMI

28.24

+0.61%↑

SLB

32.87

-0.51%↓

E

33.89

-0.12%↓

TTE.US

59.53

+0.68%↑

EQNR.US

25.23

-0.83%↓

KMI

28.24

+0.61%↑

SLB

32.87

-0.51%↓

E

33.89

-0.12%↓

TTE.US

59.53

+0.68%↑

EQNR.US

25.23

-0.83%↓

KMI

28.24

+0.61%↑

SLB

32.87

-0.51%↓

E

33.89

-0.12%↓

TTE.US

59.53

+0.68%↑

EQNR.US

25.23

-0.83%↓

KMI

28.24

+0.61%↑

SLB

32.87

-0.51%↓

E

33.89

-0.12%↓

Search

Magnolia Oil & Gas Corp (Class A)

Closed

SectorEnergy

23.76 1.45

Overview

Share price change

24h

Current

Min

23.07

Max

23.87

Key metrics

By Trading Economics

Income

18M

107M

Sales

24M

350M

P/E

Sector Avg

12.109

35.126

EPS

0.525

Dividend yield

2.36

Profit margin

30.445

Employees

252

EBITDA

22M

243M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+9.59% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.36%

5.63%

Next Earnings

29 Oct 2025

Next Dividend date

2 Sept 2025

Next Ex Dividend date

11 Aug 2025

Market Stats

By TradingEconomics

Market Cap

475M

4.7B

Previous open

22.31

Previous close

23.76

News Sentiment

By Acuity

37%

63%

45 / 145 Energy

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

Magnolia Oil & Gas Corp (Class A) Chart

Past performance is not a reliable indicator of future results.

Related News

4 Aug 2025, 21:42 UTC

Earnings
Acquisitions, Mergers, Takeovers

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 Aug 2025, 21:21 UTC

Earnings
Major Market Movers

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 Aug 2025, 20:45 UTC

Earnings

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 Aug 2025, 19:15 UTC

Major Market Movers

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 Aug 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 Aug 2025, 23:41 UTC

Market Talk

Nikkei May Rise on Fed Stimulus Hopes

4 Aug 2025, 23:28 UTC

Market Talk

Global Equities Roundup: Market Talk

4 Aug 2025, 23:28 UTC

Market Talk

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 Aug 2025, 21:30 UTC

Earnings

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 Aug 2025, 21:21 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 Aug 2025, 21:18 UTC

Earnings

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 Aug 2025, 20:25 UTC

Market Talk

India Hits Back Over Russian Oil Purchases -- Market Talk

4 Aug 2025, 20:25 UTC

Earnings

Transocean 2Q Loss $938M >RIG

4 Aug 2025, 20:25 UTC

Earnings

Transocean 2Q Loss/Shr $1.06 >RIG

4 Aug 2025, 20:18 UTC

Earnings

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 Aug 2025, 20:15 UTC

Earnings

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 Aug 2025, 20:14 UTC

Earnings

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 Aug 2025, 20:14 UTC

Earnings

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 Aug 2025, 20:14 UTC

Earnings

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 Aug 2025, 20:13 UTC

Earnings

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 Aug 2025, 20:09 UTC

Earnings

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 Aug 2025, 20:06 UTC

Earnings

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 Aug 2025, 20:01 UTC

Earnings

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 Aug 2025, 20:01 UTC

Earnings

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 Aug 2025, 20:01 UTC

Earnings

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 Aug 2025, 20:01 UTC

Earnings

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 Aug 2025, 19:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 Aug 2025, 19:28 UTC

Market Talk

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 Aug 2025, 19:07 UTC

Market Talk

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 Aug 2025, 18:27 UTC

Market Talk

Gold Climbs on Rate Cut Speculation -- Market Talk

Peer Comparison

Price change

Magnolia Oil & Gas Corp (Class A) Forecast

Price Target

By TipRanks

9.59% upside

12 Months Forecast

Average 25.7 USD  9.59%

High 30 USD

Low 19 USD

Based on 11 Wall Street analysts offering 12 month price targets forMagnolia Oil & Gas Corp (Class A) - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

11 ratings

4

Buy

5

Hold

2

Sell

Technical Score

By Trading Central

21 / 21.77Support & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

45 / 145 Energy

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Magnolia Oil & Gas Corp (Class A)

Magnolia Oil & Gas Corporation, an independent oil and natural gas company, engages in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquids reserves in the United States. Its properties are located primarily in Karnes County and the Giddings area in South Texas principally comprising the Eagle Ford Shale and the Austin Chalk formation. The company was incorporated in 2017 and is headquartered in Houston, Texas.